Article info
PDFRespiratory infection
Beyond glycaemic control: reduced pneumonia and sepsis risk with GLP-1 RAs and SGLT2 inhibitors in patients with type 2 diabetes
- Correspondence to Mr Ramin Rezaeianzadeh; ramin.rezaeianzadeh@outlook.com
Citation
Beyond glycaemic control: reduced pneumonia and sepsis risk with GLP-1 RAs and SGLT2 inhibitors in patients with type 2 diabetes
Publication history
- Accepted November 11, 2024
- First published December 7, 2024.
Online issue publication
December 23, 2024
Article Versions
- Previous version (7 December 2024).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2025. No commercial re-use. See rights and permissions. Published by BMJ Group.